Markets:

Overview

News

Currencies

International

Treasuries

Azenta, Inc. - Common Stock (NQ:AZTA)

34.89 +4.89 (+16.30%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Azenta, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Azenta (AZTA) Stock Is Up Today

November 21, 2025

Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 14.9% in the afternoon session after it reported third-quarter 2025 results that featured better-than-expected revenue and profitability.

Via StockStory

Topics Artificial Intelligence Supply Chain

Which stocks are gapping on Friday? ↗

November 21, 2025

Let's delve into the US markets on Friday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

Azenta Inc (NASDAQ:AZTA) Reports Q4 2025 Earnings Beat and Positive Market Reaction ↗

November 21, 2025

Azenta (AZTA) reports Q4 FY2025 results, beating EPS estimates with $0.21 and slightly missing on revenue. The stock rose on the positive earnings news.

Via Chartmill

Topics Earnings

Azenta (NASDAQ:AZTA) Surprises With Q3 CY2025 Sales

November 21, 2025

Life sciences company Azenta (NASDAQ:AZTA) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 5.5% year on year to $159.2 million. Its non-GAAP profit of $0.19 per...

Via StockStory

Earnings Outlook For Azenta ↗

November 20, 2025

Via Benzinga

Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings

November 19, 2025

Life sciences company Azenta (NASDAQ:AZTA) will be reporting results this Friday before the bell. Here’s what to look for.

Via StockStory

3 Unprofitable Stocks We’re Skeptical Of

November 17, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

1 Cash-Producing Stock to Consider Right Now and 2 We Avoid

November 16, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

1 Stock Under $50 for Long-Term Investors and 2 We Turn Down

November 13, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

1 High-Flying Stock with Promising Prospects and 2 That Underwhelm

November 11, 2025

"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated...

Via StockStory

3 Russell 2000 Stocks We Think Twice About

October 31, 2025

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

This Coinbase Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday ↗

October 30, 2025

Via Benzinga

3 Healthcare Stocks We Keep Off Our Radar

October 13, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the...

Via StockStory

Topics Economy Stocks

LifeStance Health Group, Azenta, PacBio, GE HealthCare, and ICU Medical Shares Are Falling, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

3 Stocks Under $50 We’re Skeptical Of

September 08, 2025

Via StockStory

Topics Supply Chain

Spotting Winners: Azenta (NASDAQ:AZTA) And Drug Development Inputs & Services Stocks In Q2

August 25, 2025

Let’s dig into the relative performance of Azenta (NASDAQ:AZTA) and its peers as we unravel the now-completed Q2 drug development inputs & services earnings season.

Via StockStory

Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know

August 22, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

Via StockStory

Topics Economy

3 Unprofitable Stocks We Steer Clear Of

August 19, 2025

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital...

Via StockStory

Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Earnings Economy

AZTA Q2 Deep Dive: Product Mix Shifts and Cost Controls Define Flat Quarter

August 13, 2025

Life sciences company Azenta (NASDAQ:AZTA) fell short of the market’s revenue expectations in Q2 CY2025, with sales flat year on year at $143.9 million. Its non-GAAP profit of $0.14 per share was in...

Via StockStory

Topics Economy

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 12, 2025

Via Benzinga

Get insights into the top gainers and losers of Tuesday's after-hours session. ↗

August 12, 2025

After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

Via Chartmill

Revvity, Avantor, Azenta, Bio-Techne, and Amneal Shares Skyrocket, What You Need To Know

August 12, 2025

A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed...

Via StockStory

Topics Bonds Economy Stocks

1 Cash-Producing Stock to Consider Right Now and 2 Facing Headwinds

August 12, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

1 Small-Cap Stock to Research Further and 2 We Turn Down

August 11, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Why Azenta (AZTA) Stock Is Up Today

August 07, 2025

Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 3.3% in the afternoon session after an upgrade from investment firm Raymond James, which lifted its rating to 'outperform' from 'market...

Via StockStory

Topics Artificial Intelligence

Azenta (AZTA) Stock Trades Up, Here Is Why

August 06, 2025

Shares of life sciences company Azenta (NASDAQ:AZTA) jumped 5% in the afternoon session after Raymond James upgraded the stock to 'Outperform' from 'Market Perform' and set a $35 price target. The...

Via StockStory

Azenta (AZTA) Q3 EPS Jumps 36% ↗

August 05, 2025

Via The Motley Fool

Why Azenta (AZTA) Stock Is Trading Lower Today

August 05, 2025

Shares of life sciences company Azenta (NASDAQ:AZTA) fell 16.3% in the afternoon session after the company announced mixed third-quarter financial results, where a failure to meet revenue targets...

Via StockStory

Topics Artificial Intelligence Stocks World Trade

Azenta Inc (NASDAQ:AZTA) Reports Mixed Q3 2025 Earnings: Revenue Miss but EPS Beat ↗

August 05, 2025

Azenta Inc (AZTA) reported mixed Q3 FY2025 results, missing revenue estimates but beating EPS. The company maintained full-year guidance amid investor caution.

Via Chartmill

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions